Showing results (861-870 of 3,376) with videos related to

Sort By:
Pageof 338
The Lancet. Oncology|May 7, 2003
Total gastrectomy: options for the restoration of gastrointestinal continuityAnthony C Chin, N Joseph Espat
The Lancet. Oncology|May 7, 2003
Management of multiple myeloma: a systematic review and critical appraisal of published studiesAmbuj Kumar, Thomas Loughran, Melissa Alsina, et al.
The Lancet. Oncology|August 7, 2003
Chemoradiation for resectable gastric cancerHenry Q Xiong, Leonard L Gunderson, James Yao, et al.
The Lancet. Oncology|June 6, 2003
Limb salvage in musculoskeletal oncologyRené Veth, René van Hoesel, Maciej Pruszczynski, et al.
The Lancet. Oncology|June 6, 2003
Relevance of DNA methylation in the management of cancerManel Esteller
The Lancet. Oncology|July 10, 2003
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancerSrikala S Sridhar, Lesley Seymour, Frances A Shepherd
The Lancet. Oncology|March 15, 2021
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trialJoaquim Bellmunt, Maha Hussain, Jürgen E Gschwend, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
The Lancet. Oncology|November 15, 2021
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal studyDavid C Qian, Troy Kleber, Brianna Brammer, et al.
The Lancet. Oncology|February 17, 2019
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trialDavid Ball, G Tao Mai, Shalini Vinod, et al.
Pageof 338